risk factors for infectious complications of anca-associated vasculitis: a cohort study. bmc nephrology (2018) 19:138
mesangial proliferative lupus nephritis with podocytopathy: a special entity of lupus nephritis. lupus,2018;27(2): 303-311
risk factors for renal survival in chinese patients with myeloperoxidase-anca-associated gn. clin j am soc nephrol, 2017;12:417-425
clinical-morphological features and outcomes of lupus podocytopathy. clin j am soc nephrol, 2016, 11(4):585-921
long-term outcome of mycophenolate mofetil treatment for patients with microscopic polyangiitis: an observational study in chinese patients. rheumatol int, 2016;36:967-974. doi 10.1007/s00296-016-3492-5
double filtration plasmapheresis in the treatment of anca associated vasculitis with severe renal failure: a preliminary study of 15 patients. therapeutic apheresis and dialysis. 2016;20(2):183-188
long-term outcomes in antineutrophil cytoplasmic autoantibody–positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 chinese patients. bmc nephrol. 2016;17:101. doi:10.1186/s12882-016-0319-2
clinic-pathological features and outcomes of patients with propylthiouracil-associated anca vasculitis with renal involvement. j nephrol (2014) 27:159–164 (if 2.02)
glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study. lupus,2015, 25:1067-1075
diffuse segmental and pure diffuse global proliferative glomerulonephritis: different patterns of class iv lupus nephritis. clin nephrol. 2014,81(6):411-418